- Home
- ZCMD vs PYPD Comparison
ZCMD vs PYPD Comparison
Compare ZCMD & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- PYPD
- Stock Information
- Founded
- ZCMD 2012
- PYPD 2008
- Country
- ZCMD China
- PYPD Israel
- Employees
- ZCMD N/A
- PYPD N/A
- Industry
- ZCMD Other Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- ZCMD Real Estate
- PYPD Health Care
- Exchange
- ZCMD Nasdaq
- PYPD Nasdaq
- Market Cap
- ZCMD 29.2M
- PYPD 34.8M
- IPO Year
- ZCMD 2020
- PYPD 2020
- Fundamental
- Price
- ZCMD N/A
- PYPD N/A
- Analyst Decision
- ZCMD
- PYPD Strong Buy
- Analyst Count
- ZCMD 0
- PYPD 5
- Target Price
- ZCMD N/A
- PYPD $12.00
- AVG Volume (30 Days)
- ZCMD 28.1K
- PYPD 49.5K
- Earning Date
- ZCMD 01-01-0001
- PYPD 11-12-2025
- Dividend Yield
- ZCMD N/A
- PYPD N/A
- EPS Growth
- ZCMD N/A
- PYPD N/A
- EPS
- ZCMD N/A
- PYPD N/A
- Revenue
- ZCMD $13,117,523.00
- PYPD N/A
- Revenue This Year
- ZCMD N/A
- PYPD N/A
- Revenue Next Year
- ZCMD N/A
- PYPD N/A
- P/E Ratio
- ZCMD N/A
- PYPD N/A
- Revenue Growth
- ZCMD N/A
- PYPD N/A
- 52 Week Low
- ZCMD $0.86
- PYPD $2.30
- 52 Week High
- ZCMD $2.50
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- ZCMD 58.04
- PYPD 45.84
- Support Level
- ZCMD $1.10
- PYPD $3.34
- Resistance Level
- ZCMD $1.30
- PYPD $3.57
- Average True Range (ATR)
- ZCMD 0.06
- PYPD 0.13
- MACD
- ZCMD 0.01
- PYPD -0.00
- Stochastic Oscillator
- ZCMD 54.35
- PYPD 31.25
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.